Novavax (NVAX) EBIT (2010 - 2026)
Novavax (NVAX) reported EBIT of -$54.91 million for Q2 2026, compared with $101.07 million a year earlier.
Analysis
Novavax (NVAX) EBIT (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Novavax's EBIT came in at -$234.12 million; for FY2025, it came in at $452.8 million.
- By year, EBIT came in at -$248.93 million in FY2024, -$566.51 million in FY2023, -$644.74 million in FY2022 and -$1.69 billion in FY2021.
- Five-year quarterly EBIT spans a low of -$824.97 million in Q4 2021 and a high of $515.51 million in Q1 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$15.43 million (Q1 2026), $14.23 million (Q4 2025) and -$178.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Novavax | 1.78 Bn | -1.22 Bn | 42.45 Mn | -54.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -54.91 Mn |
| Mar 31, 2026 | -15.43 Mn |
| Dec 31, 2025 | 14.23 Mn |
| Sep 30, 2025 | -178.02 Mn |
| Jun 30, 2025 | 101.07 Mn |
| Mar 31, 2025 | 515.51 Mn |
| Dec 31, 2024 | -131.08 Mn |
| Sep 30, 2024 | -134.02 Mn |
| Jun 30, 2024 | 161.00 Mn |
| Mar 31, 2024 | -144.83 Mn |
| Dec 31, 2023 | -183.57 Mn |
| Sep 30, 2023 | -125.63 Mn |
| Jun 30, 2023 | 55.46 Mn |
| Mar 31, 2023 | -312.77 Mn |
| Dec 31, 2022 | -243.88 Mn |
| Sep 30, 2022 | -127.19 Mn |
| Jun 30, 2022 | -482.96 Mn |
| Mar 31, 2022 | 209.29 Mn |
| Dec 31, 2021 | -824.97 Mn |
| Sep 30, 2021 | -307.14 Mn |
API Access
Novavax EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NVAX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();